$VRTX
VERTEX PHARMACEUTICALS INC / MA

2015 Q1 Form 10-Q Financial Statement

#000087532015000029 Filed on May 04, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q1
Revenue $138.5M $118.5M
YoY Change 16.93% -63.93%
Cost Of Revenue $9.381M $8.572M
YoY Change 9.44% -72.31%
Gross Profit $129.1M $109.9M
YoY Change 17.52% -63.06%
Gross Profit Margin 93.23% 92.76%
Selling, General & Admin $85.86M $74.21M
YoY Change 15.7% -19.0%
% of Gross Profit 66.49% 67.54%
Research & Development $215.6M $238.6M
YoY Change -9.65% 13.52%
% of Gross Profit 166.97% 217.16%
Depreciation & Amortization $16.36M $15.79M
YoY Change 3.64% 47.68%
% of Gross Profit 12.67% 14.37%
Operating Expenses $301.5M $312.8M
YoY Change -3.63% 3.65%
Operating Profit -$172.0M -$216.0M
YoY Change -20.39% -49.66%
Interest Expense -$21.31M -$15.72M
YoY Change 35.57% 353.07%
% of Operating Profit
Other Income/Expense, Net -$5.113M $451.0K
YoY Change -1233.7% -138.38%
Pretax Income -$198.4M -$231.3M
YoY Change -14.22% -46.68%
Income Tax $299.0K $803.0K
% Of Pretax Income
Net Earnings -$198.6M -$232.5M
YoY Change -14.56% -24.53%
Net Earnings / Revenue -143.39% -196.25%
Basic Earnings Per Share -$0.83 -$1.00
Diluted Earnings Per Share -$0.83 -$1.00
COMMON SHARES
Basic Shares Outstanding 239.5M shares 232.9M shares
Diluted Shares Outstanding 239.5M shares 232.9M shares

Balance Sheet

Concept 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.181B $1.324B
YoY Change -10.8% 6.86%
Cash & Equivalents $664.9M $424.0M
Short-Term Investments $516.0M $900.0M
Other Short-Term Assets $63.00M $35.00M
YoY Change 80.0% -68.47%
Inventory $34.09M $11.26M
Prepaid Expenses
Receivables $80.33M $59.86M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.358B $1.430B
YoY Change -5.04% -8.65%
LONG-TERM ASSETS
Property, Plant & Equipment $708.6M $726.2M
YoY Change -2.42% 44.02%
Goodwill $39.92M $30.99M
YoY Change 28.79% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.952M $9.452M
YoY Change -15.87% 8.73%
Total Long-Term Assets $807.6M $766.8M
YoY Change 5.33% -7.22%
TOTAL ASSETS
Total Short-Term Assets $1.358B $1.430B
Total Long-Term Assets $807.6M $766.8M
Total Assets $2.166B $2.197B
YoY Change -1.42% -8.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $43.52M $49.57M
YoY Change -12.2% -16.86%
Accrued Expenses $177.0M $234.4M
YoY Change -24.49% -14.48%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $48.00M $18.00M
YoY Change 166.67% 125.0%
Total Short-Term Liabilities $302.4M $373.5M
YoY Change -19.03% -8.37%
LONG-TERM LIABILITIES
Long-Term Debt $786.0M $523.0M
YoY Change 50.29% -28.55%
Other Long-Term Liabilities $32.70M $12.03M
YoY Change 171.79% -27.87%
Total Long-Term Liabilities $32.70M $12.03M
YoY Change 171.79% -27.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $302.4M $373.5M
Total Long-Term Liabilities $32.70M $12.03M
Total Liabilities $1.168B $966.2M
YoY Change 20.91% -31.73%
SHAREHOLDERS EQUITY
Retained Earnings -$4.904B -$4.199B
YoY Change 16.78% 9.65%
Common Stock $5.880B $5.431B
YoY Change 8.27% 18.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $976.5M $1.231B
YoY Change
Total Liabilities & Shareholders Equity $2.166B $2.197B
YoY Change -1.42% -8.16%

Cashflow Statement

Concept 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$198.6M -$232.5M
YoY Change -14.56% -24.53%
Depreciation, Depletion And Amortization $16.36M $15.79M
YoY Change 3.64% 47.68%
Cash From Operating Activities -$222.2M -$175.8M
YoY Change 26.44% 167.2%
INVESTING ACTIVITIES
Capital Expenditures $10.56M $15.53M
YoY Change -32.0% -6.51%
Acquisitions
YoY Change
Other Investing Activities -$799.0K $476.0K
YoY Change -267.86% -200.85%
Cash From Investing Activities $214.0M -$20.40M
YoY Change -1149.21% -45.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $50.41M 50.40M
YoY Change 0.03% -926.23%
NET CHANGE
Cash From Operating Activities -$222.2M -$175.8M
Cash From Investing Activities $214.0M -20.40M
Cash From Financing Activities $50.41M 50.40M
Net Change In Cash $42.22M -$175.8M
YoY Change -124.02% 167.2%
FREE CASH FLOW
Cash From Operating Activities -$222.2M -$175.8M
Capital Expenditures $10.56M $15.53M
Free Cash Flow -$232.8M -$191.3M
YoY Change 21.7% 132.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q1 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015Q1 dei Document Type
DocumentType
10-Q
CY2015Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000875320
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
243752247 shares
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2015Q1 dei Entity Registrant Name
EntityRegistrantName
VERTEX PHARMACEUTICALS INC / MA
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
71194000 USD
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
43524000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
75964000 USD
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
80332000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
209676000 USD
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
176981000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-306000 USD
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-297000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
917000 USD
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
791000 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5777154000 USD
CY2015Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5877324000 USD
CY2014Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
46787000 USD
CY2015Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
58268000 USD
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
46580000 USD
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
57384000 USD
CY2011Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
1100000 sqft
CY2014Q4 us-gaap Assets
Assets
2334679000 USD
CY2015Q1 us-gaap Assets
Assets
2165827000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
1546511000 USD
CY2015Q1 us-gaap Assets Current
AssetsCurrent
1358203000 USD
CY2014Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
761847000 USD
CY2015Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
516255000 USD
CY2014Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
17806000 USD
CY2015Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
19672000 USD
CY2014Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
3619000 USD
CY2015Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 USD
CY2014Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
39293000 USD
CY2015Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
46471000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
569299000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
424045000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
625259000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
664879000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
241764398 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
243580032 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
241764398 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
243580032 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
2385000 USD
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
2399000 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-232448000 USD
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-198732000 USD
CY2015Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
9381000 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2015Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-98000 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-232448000 USD
CY2015Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-198830000 USD
CY2014Q1 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
CY2015Q1 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
964000 USD
CY2014Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
8572000 USD
CY2014Q1 us-gaap Costs And Expenses
CostsAndExpenses
334493000 USD
CY2015Q1 us-gaap Costs And Expenses
CostsAndExpenses
310494000 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
17468000 USD
CY2015Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
15918000 USD
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
27808000 USD
CY2015Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
24000000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
15044000 USD
CY2015Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
15093000 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15788000 USD
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16363000 USD
CY2014Q4 us-gaap Derivative Asset Not Offset Policy Election Deduction
DerivativeAssetNotOffsetPolicyElectionDeduction
0 USD
CY2015Q1 us-gaap Derivative Asset Not Offset Policy Election Deduction
DerivativeAssetNotOffsetPolicyElectionDeduction
617000 USD
CY2014Q4 us-gaap Derivative Assets
DerivativeAssets
2011000 USD
CY2015Q1 us-gaap Derivative Assets
DerivativeAssets
2934000 USD
CY2014Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
2011000 USD
CY2015Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
2934000 USD
CY2014Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
2011000 USD
CY2015Q1 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
2317000 USD
CY2015Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
617000 USD
CY2015Q1 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
0 USD
CY2015Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
617000 USD
CY2015Q1 us-gaap Derivative Liability Not Offset Policy Election Deduction
DerivativeLiabilityNotOffsetPolicyElectionDeduction
617000 USD
CY2014Q1 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
6904000 USD
CY2015Q1 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
2926000 USD
CY2014Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0 USD
CY2015Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0 USD
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.00
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.83
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.00
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.83
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
499000 USD
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-2596000 USD
CY2014Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
207000 USD
CY2015Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
884000 USD
CY2014Q4 us-gaap Foreign Currency Cash Flow Hedge Asset At Fair Value
ForeignCurrencyCashFlowHedgeAssetAtFairValue
2011000 USD
CY2015Q1 us-gaap Foreign Currency Cash Flow Hedge Asset At Fair Value
ForeignCurrencyCashFlowHedgeAssetAtFairValue
2934000 USD
CY2014Q4 us-gaap Foreign Currency Cash Flow Hedge Liability At Fair Value
ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
0 USD
CY2015Q1 us-gaap Foreign Currency Cash Flow Hedge Liability At Fair Value
ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
617000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
39915000 USD
CY2015Q1 us-gaap Goodwill
Goodwill
39915000 USD
CY2014Q1 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2015Q1 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-232111000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-198606000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-231308000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-198405000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-232111000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-198704000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.00
CY2015Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.83
CY2014Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.00
CY2015Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.83
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-346000 USD
CY2015Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 USD
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-346000 USD
CY2015Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2015Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2015Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
803000 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
299000 USD
CY2014Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
140000 USD
CY2015Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
60000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
978000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-23556000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-25237000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5863000 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-13536000 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-5866000 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1756000 USD
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-5333000 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2488000 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2635000 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
17937000 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15233000 USD
CY2014Q1 us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
0 USD
CY2015Q1 us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
21971000 USD
CY2014Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-15717000 USD
CY2015Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-21307000 USD
CY2014Q1 us-gaap Interest Paid
InterestPaid
15970000 USD
CY2015Q1 us-gaap Interest Paid
InterestPaid
6483000 USD
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1834000 USD
CY2015Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3692000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
30848000 USD
CY2015Q1 us-gaap Inventory Net
InventoryNet
34089000 USD
CY2014Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
8506000 USD
CY2015Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
7833000 USD
CY2014Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
20508000 USD
CY2015Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
22564000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
1238496000 USD
CY2015Q1 us-gaap Liabilities
Liabilities
1168290000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2334679000 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2165827000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
368254000 USD
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
302438000 USD
CY2014Q4 us-gaap Minority Interest
MinorityInterest
21177000 USD
CY2015Q1 us-gaap Minority Interest
MinorityInterest
21079000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-145254000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
39620000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
50416000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
35359000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-20407000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
214038000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-175762000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-207181000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-232457000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-198606000 USD
CY2014Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2015Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-98000 USD
CY2014Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
25564000 USD
CY2015Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 USD
CY2015Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-216042000 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-171985000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3265000 USD
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7952000 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
6000 USD
CY2015Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
1572000 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
72000 USD
CY2015Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-608000 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9000 USD
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-126000 USD
CY2014Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-36000 USD
CY2015Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
306000 USD
CY2014Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-27000 USD
CY2015Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
176000 USD
CY2014Q4 us-gaap Other Indefinite Lived Intangible Assets
OtherIndefiniteLivedIntangibleAssets
29000000 USD
CY2015Q1 us-gaap Other Indefinite Lived Intangible Assets
OtherIndefiniteLivedIntangibleAssets
29000000 USD
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4797000 USD
CY2015Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4683000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
21707000 USD
CY2015Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32696000 USD
CY2014Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
173000 USD
CY2015Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-629000 USD
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
451000 USD
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5113000 USD
CY2014Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
476000 USD
CY2015Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-799000 USD
CY2014Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2622000 USD
CY2015Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
4497000 USD
CY2014Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
380949000 USD
CY2015Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
125655000 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15526000 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10558000 USD
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
52593000 USD
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
62648000 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
60134000 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
41616000 USD
CY2014Q1 us-gaap Proceeds From Long Term Capital Lease Obligations
ProceedsFromLongTermCapitalLeaseObligations
0 USD
CY2015Q1 us-gaap Proceeds From Long Term Capital Lease Obligations
ProceedsFromLongTermCapitalLeaseObligations
13386000 USD
CY2014Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
8050000 USD
CY2015Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2014Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
376544000 USD
CY2015Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
371423000 USD
CY2014Q1 us-gaap Profit Loss
ProfitLoss
-232457000 USD
CY2015Q1 us-gaap Profit Loss
ProfitLoss
-198704000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
715812000 USD
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
708616000 USD
CY2014Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-3000 USD
CY2015Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
1698000 USD
CY2014Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
15146000 USD
CY2015Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
15146000 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
238617000 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
215599000 USD
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
176000 USD
CY2015Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
22141000 USD
CY2014Q1 us-gaap Restructuring Charges
RestructuringCharges
6188000 USD
CY2015Q1 us-gaap Restructuring Charges
RestructuringCharges
-3272000 USD
CY2014Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
33107000 USD
CY2015Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
13133000 USD
CY2014Q4 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
12748000 USD
CY2015Q1 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
8355000 USD
CY2014Q1 us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
-4486000 USD
CY2015Q1 us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
-24367000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4705450000 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4904056000 USD
CY2014Q1 us-gaap Revenues
Revenues
118451000 USD
CY2015Q1 us-gaap Revenues
Revenues
138509000 USD
CY2014Q1 us-gaap Royalty Revenue
RoyaltyRevenue
10733000 USD
CY2015Q1 us-gaap Royalty Revenue
RoyaltyRevenue
6792000 USD
CY2014Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
103461000 USD
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
130875000 USD
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
74212000 USD
CY2015Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
85860000 USD
CY2014Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
280569000 USD
CY2015Q1 us-gaap Senior Long Term Notes
SeniorLongTermNotes
266266000 USD
CY2014Q4 us-gaap Senior Notes Current
SeniorNotesCurrent
14206000 USD
CY2015Q1 us-gaap Senior Notes Current
SeniorNotesCurrent
28527000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
46580000 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
57384000 USD
CY2015Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
5410000 shares
CY2015Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
12682000 shares
CY2015Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
47.36
CY2015Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
65.17
CY2015Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y3M11D
CY2014Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
60134000 USD
CY2015Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
41916000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
1075006000 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
976458000 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1356405000 USD
CY2014Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1230878000 USD
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1096183000 USD
CY2015Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
997537000 USD
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
900000 USD
CY2015Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
900000 USD
CY2015Q1 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
-1625000 USD
CY2014Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
36023000 USD
CY2015Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
33552000 USD
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
232887000 shares
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
239493000 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
232887000 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
239493000 shares
CY2014Q4 vrtx Cash Cash Equivalents And Available For Sale Securities Fair Value
CashCashEquivalentsAndAvailableForSaleSecuritiesFairValue
1387106000 USD
CY2015Q1 vrtx Cash Cash Equivalents And Available For Sale Securities Fair Value
CashCashEquivalentsAndAvailableForSaleSecuritiesFairValue
1181134000 USD
CY2014Q4 vrtx Cash Cash Equivalents Available For Sale Securities Amortized Cost
CashCashEquivalentsAvailableForSaleSecuritiesAmortizedCost
1387229000 USD
CY2015Q1 vrtx Cash Cash Equivalents Available For Sale Securities Amortized Cost
CashCashEquivalentsAvailableForSaleSecuritiesAmortizedCost
1181081000 USD
CY2014Q4 vrtx Cash Cash Equivalents Availableforsale Securities Gross Unrealized Gain
CashCashEquivalentsAvailableforsaleSecuritiesGrossUnrealizedGain
88000 USD
CY2015Q1 vrtx Cash Cash Equivalents Availableforsale Securities Gross Unrealized Gain
CashCashEquivalentsAvailableforsaleSecuritiesGrossUnrealizedGain
93000 USD
CY2014Q4 vrtx Cash Cash Equivalents Availableforsale Securities Unrealized Loss Gross
CashCashEquivalentsAvailableforsaleSecuritiesUnrealizedLossGross
211000 USD
CY2015Q1 vrtx Cash Cash Equivalents Availableforsale Securities Unrealized Loss Gross
CashCashEquivalentsAvailableforsaleSecuritiesUnrealizedLossGross
40000 USD
CY2014Q1 vrtx Collaborative Revenues
CollaborativeRevenues
4257000 USD
CY2015Q1 vrtx Collaborative Revenues
CollaborativeRevenues
842000 USD
CY2014Q4 vrtx Construction Financing Obligation Noncurrent
ConstructionFinancingObligationNoncurrent
473073000 USD
CY2015Q1 vrtx Construction Financing Obligation Noncurrent
ConstructionFinancingObligationNoncurrent
472971000 USD
CY2014Q4 vrtx Constructionfinancingleaseobligationcurrentandnoncurrent
Constructionfinancingleaseobligationcurrentandnoncurrent
473400000 USD
CY2015Q1 vrtx Constructionfinancingleaseobligationcurrentandnoncurrent
Constructionfinancingleaseobligationcurrentandnoncurrent
473300000 USD
CY2015Q1 vrtx Deferred Revenue Royalty Purchase Agreement
DeferredRevenueRoyaltyPurchaseAgreement
39200000 USD
CY2014Q4 vrtx Derivative Asset Fair Value Gross Asset Collateral And Other Set Off Against Gross Assets Subject To Offsetting Enforceable Master Netting Arrangement Or Similar Agreement
DerivativeAssetFairValueGrossAssetCollateralAndOtherSetOffAgainstGrossAssetsSubjectToOffsettingEnforceableMasterNettingArrangementOrSimilarAgreement
0 USD
CY2015Q1 vrtx Derivative Asset Fair Value Gross Asset Collateral And Other Set Off Against Gross Assets Subject To Offsetting Enforceable Master Netting Arrangement Or Similar Agreement
DerivativeAssetFairValueGrossAssetCollateralAndOtherSetOffAgainstGrossAssetsSubjectToOffsettingEnforceableMasterNettingArrangementOrSimilarAgreement
0 USD
CY2015Q1 vrtx Derivative Liability Fair Value Gross Liability Collateral And Other Set Off Against Gross Assets Subject To Offsetting Enforceable Master Netting Arrangement Or Similar Agreement
DerivativeLiabilityFairValueGrossLiabilityCollateralAndOtherSetOffAgainstGrossAssetsSubjectToOffsettingEnforceableMasterNettingArrangementOrSimilarAgreement
0 USD
CY2011 vrtx Lease Agreement Number Of Leases
LeaseAgreementNumberOfLeases
2 lease
CY2011 vrtx Lease Agreements Number Of Buildings
LeaseAgreementsNumberOfBuildings
2 building
CY2011 vrtx Optional Term Of Lease Agreement
OptionalTermOfLeaseAgreement
P10Y
CY2008 vrtx Proceeds From Sale Of Royalty Rights
ProceedsFromSaleOfRoyaltyRights
160000000 USD
CY2015Q1 vrtx Unrecognized Tax Benefits Reduction Resultingfrom Lapseof Applicable Statuteof Limitationsand Settlementswith Taxing Authorities Estimatedin Next Fiscal Year
UnrecognizedTaxBenefitsReductionResultingfromLapseofApplicableStatuteofLimitationsandSettlementswithTaxingAuthoritiesEstimatedinNextFiscalYear
500000 USD
CY2015Q1 vrtx Valuation Allowances And Reserves Provision
ValuationAllowancesAndReservesProvision
11233000 USD
CY2015Q1 vrtx Valuation Allowances And Reserves Sales Credits Or Payments Current
ValuationAllowancesAndReservesSalesCreditsOrPaymentsCurrent
12079000 USD
CY2015Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates and Summary of Significant Accounting Policies</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the amounts of revenues and expenses during the reported periods. Significant estimates in these condensed consolidated financial statements have been made in connection with the calculation of revenues, inventories, research and development expenses, stock-based compensation expense, restructuring expense, the fair value of intangible assets, noncontrolling interest, the consolidation of VIEs, leases and the provision for or benefit from income taxes. The Company bases its estimates on historical experience and various other assumptions, including in certain circumstances future projections that management believes to be reasonable under the circumstances. Actual results could differ from those estimates. Changes in estimates are reflected in reported results in the period in which they become known.</font></div><div style="line-height:120%;padding-bottom:12px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's significant accounting policies are described in Note&#160;A, "Nature of Business and Accounting Policies," in the </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> Annual Report on Form&#160;10-K.</font></div></div>

Files In Submission

Name View Source Status
0000875320-15-000029-index-headers.html Edgar Link pending
0000875320-15-000029-index.html Edgar Link pending
0000875320-15-000029.txt Edgar Link pending
0000875320-15-000029-xbrl.zip Edgar Link pending
a2015q110-q.htm Edgar Link pending
a2015q110-q_exhibit311.htm Edgar Link pending
a2015q110-q_exhibit312.htm Edgar Link pending
a2015q110-q_exhibit321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrtx-20150331.xml Edgar Link completed
vrtx-20150331.xsd Edgar Link pending
vrtx-20150331_cal.xml Edgar Link unprocessable
vrtx-20150331_def.xml Edgar Link unprocessable
vrtx-20150331_lab.xml Edgar Link unprocessable
vrtx-20150331_pre.xml Edgar Link unprocessable
vrtx10q_exhibit101.htm Edgar Link pending
vrtx10q_exhibit102.htm Edgar Link pending